Eliana Clark - Net Worth and Insider Trading
Eliana Clark Net Worth
The estimated net worth of Eliana Clark is at least $866,216 dollars as of 2024-12-26. Eliana Clark is the EVP, Chief Technical Officer of Intellia Therapeutics Inc and owns about 71,470 shares of Intellia Therapeutics Inc (NTLA) stock worth over $866,216. Details can be seen in Eliana Clark's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eliana Clark has not made any transactions after 2024-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eliana Clark
Eliana Clark Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eliana Clark owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .
Click here to see the complete history of Eliana Clark’s form 4 insider trades.
Insider Ownership Summary of Eliana Clark
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NTLA | Intellia Therapeutics Inc | 2024-07-01 | EVP & Chief Technical Officer |
Eliana Clark Latest Holdings Summary
Eliana Clark currently owns a total of 1 stock. Eliana Clark owns 71,470 shares of Intellia Therapeutics Inc (NTLA) as of July 1, 2024, with a value of $866,216.
Latest Holdings of Eliana Clark
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NTLA | Intellia Therapeutics Inc | 2024-07-01 | 71,470 | 12.12 | 866,216 |
Holding Weightings of Eliana Clark
Eliana Clark Form 4 Trading Tracker
According to the SEC Form 4 filings, Eliana Clark has made a total of 5 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 405 shares on July 1, 2024, which brought Eliana Clark around $9,287.
Insider Trading History of Eliana Clark
- 1
Eliana Clark Trading Performance
Eliana Clark Ownership Network
Eliana Clark Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Eliana Clark is the EVP & Chief Technical Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Scientific Officer Laura Sepp-lorenzino , EVP & Chief Business Officer Derek Hicks , and director & President and CEO John M. Leonard .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Eliana Clark made 3 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 5,373. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 2,397 shares made by Muna Bhanji , a net sale of 7,807 shares made by Laura Sepp-lorenzino , and a net sale of 19,223 shares made by John M. Leonard .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 57,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 57,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Eliana Clark Mailing Address
Above is the net worth, insider trading, and ownership report for Eliana Clark. You might contact Eliana Clark via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge Ma 02139.